Finance

Beta
Lists
TPST:NASDAQ
Tempest Therapeutics Inc
$1.08
+2.86%
(+0.030) 1D
Jun 26, 4:00:01 PM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for TPST...
Open
$1.07
High
$1.10
Low
$1.03
Mkt. cap
15.99M
Avg. vol.
156.98K
Volume
0.00
52-wk high
$12.23
52-wk low
$1.02
EPS
-$6.21
Beta
-1.85
Shares outstanding
14.81M
No. of employees
5
Open
$1.07
High
$1.10
Low
$1.03
Mkt. cap
15.99M
Avg. vol.
156.98K
Volume
0.00
52-wk high
$12.23
52-wk low
$1.02
EPS
-$6.21
Beta
-1.85
Shares outstanding
14.81M
No. of employees
5
News stories
From sources across the web
About Tempest Therapeutics Inc
CEOStephen R. Brady
Employees5
Founded2011
HeadquartersBrisbane, California, United States
SectorBiotechnology
Websitetempesttx.com
Analyst ratings
Based on 1 analyst giving stock ratings to TPST in the past 3 months
Buy
Buy
1
Hold
0
Sell
0
12-month forecast
Based on 1 Wall Street analyst offering 12-month price targets for TPST in the last 3 months
Highest
Current $1.08
$11.00 (+918.52%)
Average
$11.00 (+918.52%)
Lowest
$11.00 (+918.52%)
Analyst
Recommendation
Action
Price target
Projected
Date
Joseph Pantginis
H.C. Wainwright
Buy
Reiterated
$11.00
+918.5%
03/31/2026
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
-
-
-
-
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
3.87M
570.00K
539.00K
114.00K
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
4.10M
3.03M
3.54M
5.42M
Operating expense
7.97M
3.60M
4.08M
5.54M
Total operating expenses
7.97M
3.60M
4.08M
5.54M
Operating income
-7.97M
-3.60M
-4.08M
-5.54M
Other non operating income
-
-
-
-
EBT including unusual items
-7.87M
-3.51M
-4.02M
-27.70M
EBT excluding unusual items
-7.87M
-3.51M
-4.02M
-5.52M
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-7.87M
-3.51M
-4.02M
-27.70M
Net profit margin
-
-
-
-
Earnings per share
-2.07
-0.79
-0.62
-0.50
Interest and investment income
142.00K
86.00K
56.00K
23.00K
Interest expense
-46.00K
-
-
-
Net interest expenses
96.00K
86.00K
56.00K
23.00K
Depreciation and amortization charges
-
-
-
-
EBITDA
-7.90M
-3.53M
-4.01M
-5.48M
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

What's on your mind?
Give me an overview of TPST
Explore what’s possible
Deep Search
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer